COPD Clinical Trials in Gifu
2 recruitingGifu, Japan
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled266 locationsNCT06878261
Recruiting
Zephyr Valve Japan Post-Marketing Surveillance
COPDEmphysemaSevere Emphysema
Pulmonx Corporation140 enrolled17 locationsNCT06332885